Start from the complication
Restenosis, infection, fibrosis, scarring. The failure mode defines the drug, the dose and the release profile — not the other way around.
Research
Combining pharmaceuticals with innovative device designs.
Our research emphasises reducing complications associated with implanted medical devices, surgical procedures, and acute injuries. We develop technologies spanning interventional oncology, wound closure, ophthalmology, and the biomaterials used in medical implants.
Deliver locally
A device already sits at the site of treatment. Using it as the delivery vehicle concentrates therapy there and limits systemic exposure.
Design the material, not just the drug
Coating chemistry, polymer selection and surface finish determine elution kinetics and long-term tissue response.
Carry learning across fields
Insight from cardiovascular elution informs oncology, ophthalmology and wound closure, and vice versa.
A legacy of drug elution
Work on paclitaxel-coated medical devices helped establish the concept of drug-eluting devices in cardiovascular medicine and influenced later generations of combination medical technologies. That precedent still shapes how we evaluate every new programme.